Glenn John, CFO of IRADIMED CORP ($IRMD), sold shares on the open market three times in the last year, totaling $2.36 million. His most recent sale occurred on December 11, 2025. These sales rank 3,156th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. John made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 8907 | $0.00 | 8,907.0000 | 12,854,000 | 9999.99% | 0.07% |
| Dec. 11, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Common Stock | 1812 | $0.00 | 9,174.0000 | 12,860,077 | 24.61% | 0.01% |
| Dec. 11, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | S | Common Stock | 14468 | $97.26 | 7,894.0000 | 12,860,077 | 64.70% | 0.11% |
| Dec. 11, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | S | Common Stock | 532 | $98.09 | 7,362.0000 | 12,860,077 | 6.74% | 0.00% |
| Dec. 11, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 1812 | $0.00 | 3,624.0000 | 12,860,077 | 33.33% | 0.01% |
| Dec. 11, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | F | Common Stock | 714 | $97.38 | 8,460.0000 | 12,860,077 | 7.78% | 0.01% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 10504 | $0.00 | 0.0000 | 12,860,077 | 100.00% | 0.08% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Performance-based Restricted Stock Units | 21008 | $0.00 | 0.0000 | 12,860,077 | 100.00% | 0.16% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Common Stock | 10504 | $0.00 | 13,004.0000 | 12,860,077 | 420.16% | 0.08% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | F | Common Stock | 3383 | $94.57 | 9,621.0000 | 12,860,077 | 26.02% | 0.03% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Common Stock | 21008 | $0.00 | 30,629.0000 | 12,860,077 | 218.36% | 0.16% |
| Dec. 7, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | F | Common Stock | 8267 | $94.57 | 22,362.0000 | 12,860,077 | 26.99% | 0.06% |
| Nov. 10, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | S | Common Stock | 10651 | $84.51 | 2,500.0000 | 12,860,077 | 80.99% | 0.08% |
| June 20, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Common Stock | 5796 | $0.00 | 14,563.0000 | 12,825,672 | 66.11% | 0.05% |
| June 20, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | F | Common Stock | 1412 | $58.24 | 13,151.0000 | 12,825,672 | 9.70% | 0.01% |
| June 20, 2025 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 5796 | $0.00 | 5,796.0000 | 12,825,672 | 50.00% | 0.05% |
| June 20, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 5796 | $0.00 | 11,592.0000 | 12,749,973 | 33.33% | 0.05% |
| June 20, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Common Stock | 5796 | $0.00 | 10,179.0000 | 12,749,973 | 132.24% | 0.05% |
| June 20, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | F | Common Stock | 1412 | $42.53 | 8,767.0000 | 12,749,973 | 13.87% | 0.01% |
| June 20, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 5796 | $0.00 | 11,592.0000 | 12,749,973 | 100.00% | 0.05% |
| Dec. 11, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | A | Performance-based Restricted Stock Units | 5435 | $0.00 | 23,119.0000 | 12,778,446 | 30.73% | 0.04% |
| Dec. 11, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 5436 | $0.00 | 40,508.0000 | 12,778,446 | 15.50% | 0.04% |
| Dec. 2, 2024 | IRADIMED CORP | $IRMD | GLENN JOHN | CHIEF FINANCIAL OFFICER | S | Common Stock | 2500 | $54.18 | 4,383.0000 | 12,778,446 | 36.32% | 0.02% |